2026-01-15 - Analysis Report
# Financial Report

## Company Overview
Intuitive Surgical Inc, a medical technology company.

## Return Rate Comparison

### Cumulative Return
- Review stock (ISRG): **78.50%**
- Comparison stock (VOO): **93.94%**

### Divergence
- Degree of divergence: **-15.40** (current)
- Relative divergence: **26.80%**
- Maximum fluctuation range: **73.30** (max) / **-47.80** (min)

## Alpha, Beta Analysis
| Period | CAGR | MDD | Alpha | Beta | Cap (B) |
|--------|------|-----|-------|------|---------|
| 2016-2018 | 49.0% | 29.0% | 45.0% | 1.2 | 55.7B |
| 2017-2019 | 40.0% | 29.0% | 23.0% | 1.4 | 68.7B |
| 2018-2020 | -8.0% | 29.0% | -29.0% | 1.2 | 95.1B |
| 2019-2021 | 26.0% | 21.1% | -17.0% | 1.2 | 125.3B |
| 2020-2022 | -18.0% | 48.9% | -16.0% | 1.2 | 92.5B |
| 2021-2023 | -12.0% | 48.9% | -13.0% | 1.4 | 117.7B |
| 2022-2024 | 35.0% | 38.0% | 16.0% | 1.3 | 182.0B |
| 2023-2025 | 60.0% | 28.0% | -2.0% | 1.2 | 197.5B |

## Recent Stock Price Fluctuations

- Close price: **$561.82**
- Last market price: **$546.87**
- 5-day Moving Average (SMA): **$579.63**
- 20-day SMA: **$572.56**
- 60-day SMA: **$556.73**

## RSI, PPO Index Indicators and Delta

- Market Risk Indicator (MRI): **0.70**
- RSI: **39.20**
- PPO: **-0.25**
- Expected Return: **5.30%**
- Recent (20 days) relative divergence change: **-8.50**
- 7-day Rank change: **-21**
- 7-day Dynamic Expected Return change: **1.00**

## News & Significant Events (from news.google.com)

- [2026-01-14] Intuitive stock falls despite strong Q4 procedure growth, revenue beat - Investing.com
- [2026-01-14] Why Intuitive Surgical Stock Dropped Today - Yahoo Finance
- [2026-01-12] Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: What You Should Know - Nasdaq
- [2026-01-14] Why This Robotics Giant Crumbled Despite Its Quarterly Beat - Investor's Business Daily
- [2026-01-14] Intuitive Surgical (NASDAQ:ISRG) Shares Gap Down - What's Next? - MarketBeat
- [2026-01-14] A Look At Intuitive Surgical (ISRG) Valuation As AI Surgery Expectations Build Ahead Of Earnings - simplywall.st

## Analyst Opinions
```text
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.06 (~Buy)
- Opinions: 29
- Target Price (avg/high/low): 608.26 / 740.00 / 378.00
```

## Recent Earnings Analysis
| Quarter | EPS | Revenue (B$) |
|---------|-----|---------------|
| 2025-10-22 | 1.98 | 2.51B |
| 2025-07-23 | 1.84 | 2.44B |
| 2025-04-23 | 1.95 | 2.25B |
| 2024-10-18 | 1.59 | 2.04B |
| 2025-10-22 | 1.59 | 2.04B |

## Financial Information

### Revenue and Profitability
| Quarter | Revenue (B$) | Profit Margin |
|---------|---------------|---------------|
| 2025-09-30 | $2.51B | 66.36% |
| 2025-06-30 | $2.44B | 66.31% |
| 2025-03-31 | $2.25B | 64.69% |
| 2024-12-31 | $2.41B | 68.04% |
| 2024-09-30 | $2.04B | 67.41% |

### Capital and Profitability
| Quarter | Equity (B$) | ROE |
|---------|---------------|-----|
| 2025-09-30 | $16.93B | 4.16% |
| 2025-06-30 | $17.85B | 3.69% |
| 2025-03-31 | $17.11B | 4.08% |
| 2024-12-31 | $16.43B | 4.17% |
| 2024-09-30 | $15.58B | 3.63% |

## Comprehensive Analysis

- Intuitive Surgical Inc has shown volatile returns over the years, with a cumulative return of **78.50%** compared to the **93.94%** returns of the S&P 500.
- The company's alpha and beta values indicate a potential for higher returns with a moderate level of risk.
- Recent stock price fluctuations show a decline, with the closing price at **$561.82** and the last market price at **$546.87**.
- Market risk indicators and RSI scores suggest a medium-risk investment opportunity.
- Expected returns are projected at **5.30%**.
- Recent news coverage indicates a mixed performance, with the stock falling despite strong Q4 procedure growth and revenue beat.
- Analyst opinions are generally positive, with a mean rating of 2.06 (~Buy) and a target price of 608.26.
- Recent earnings analysis shows a stable revenue growth, but a slight decline in profit margins.
- Financial information indicates a strong capital position and stable profitability.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.